Green Generics Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 91.11%
- Ebitda 91.11%
- Net Worth -2.34%
- Total Assets -17.79%
About Green Generics
Green Generics Private Limited (GGPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 November 2010 and has a history of 14 years and two months. Its registered office is in Gurugram, Haryana, India.
The Corporate was formerly known as Ecogreen Kleen Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Alok Srivastava, Jhooma Srivastava, and Arjun Srivastava serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74140HR2010PTC098025
- Company No.
210744
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Green Generics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jhooma Srivastava  | Director | 24-Nov-2010 | Current |
| Alok Srivastava | Director | 24-Nov-2010 | Current |
| Arjun Srivastava | Director | 04-Oct-2011 | Current |
Financial Performance of Green Generics.
Green Generics Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 91.11% increase in profit. The company's net worth dipped by a decrease of 2.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Green Generics?
In 2021, Green Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apac Sourcing Solutions LimitedAlok Srivastava, Jhooma Srivastava and 1 more are mutual person
Mbatrek Private LimitedAlok Srivastava and Jhooma Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Green Generics?
Unlock and access historical data on people associated with Green Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Green Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Green Generics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.